Practice Management News

This month’s roundtable features a group of budding rheumatologists, still in training, who share their thoughts on how to sort out, define and achieve their goals in the workplace.

Many rheumatologists working today have navigated the specialty from the era of deeply flawed treatments like gold, through epoch-defining shifts brought on by biologics, biosimilars and, most recently, the unexpected crisis of COVID-19.

Time in the market is far more important than timing the market. Long-term investors will utilize both the strategies of dollar cost averaging and lump sum investing to reach their investment goals.

The FDA approved AstraZeneca’s Fasenra for the treatment of adult patients with eosinophilic granulomatosis with polyangiitis, or EGPA, according to a company press release.

A novel remote monitoring app could help patients provide real-time information about their disease — including flares and other health care visits — to their rheumatologist in the long durations between visits.

Every September, a national spotlight shines on rheumatic diseases, a wide-ranging group of more than 100 different conditions that shape the lives of millions of people every day.

The 2024 election is one of the most consequential elections in recent history, and as physicians, we have a responsibility to vote.

Most physicians and residents report feelings of burnout, while stigma about receiving mental health care remains prevalent, according to a new report from The Physicians Foundation.

Saving money at an early age is perhaps the simplest and one of the most effective methods to accumulate wealth.

Protecting immunocompromised individuals from infections like herpes zoster is an ongoing challenge for every rheumatologist.